Argo advises 3d investors on participation in Univercells

Argo advised 3d investors on its participation in the 44m series D round of global life sciences company Univercells in October 2022. 3d investors invested alongside existing and new shareholders, including Adjuvant, SFPI-FPIM and the Global Health Investment Corporation.